Neumora Therapeutics Inc (NASDAQ: NMRA) on Tuesday, soared 6.75% from the previous trading day, before settling in for the closing price of $1.63. Within the past 52 weeks, NMRA’s price has moved between $0.61 and $17.19.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 7.56%. With a float of $65.29 million, this company’s outstanding shares have now reached $161.95 million.
Neumora Therapeutics Inc (NMRA) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Neumora Therapeutics Inc is 59.69%, while institutional ownership is 22.97%. The most recent insider transaction that took place on Mar 12 ’25, was worth 21,450. Before that another transaction happened on Feb 18 ’25, when Company’s insider sold 13,871 for $1.69, making the entire transaction worth $23,468. This insider now owns 7,405,004 shares in total.
Neumora Therapeutics Inc (NMRA) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.45 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.38) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
Neumora Therapeutics Inc (NASDAQ: NMRA) Trading Performance Indicators
Neumora Therapeutics Inc (NMRA) is currently performing well based on its current performance indicators. A quick ratio of 10.54 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.57, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -1.07 in one year’s time.
Technical Analysis of Neumora Therapeutics Inc (NMRA)
The latest stats from [Neumora Therapeutics Inc, NMRA] show that its last 5-days average volume of 0.43 million was inferior to 2.02 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 64.49%.
During the past 100 days, Neumora Therapeutics Inc’s (NMRA) raw stochastic average was set at 50.42%, which indicates a significant decrease from 89.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1206 in the past 14 days, which was lower than the 0.1257 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4148, while its 200-day Moving Average is $3.0944. Now, the first resistance to watch is $1.8133. This is followed by the second major resistance level at $1.8867. The third major resistance level sits at $1.9933. If the price goes on to break the first support level at $1.6333, it is likely to go to the next support level at $1.5267. The third support level lies at $1.4533 if the price breaches the second support level.
Neumora Therapeutics Inc (NASDAQ: NMRA) Key Stats
Market capitalization of the company is 281.79 million based on 161,945K outstanding shares. Right now, sales total 0 K and income totals -243,790 K. The company made 0 K in profit during its latest quarter, and -52,730 K in sales during its previous quarter.
